Price Alert

Global Medical REIT Inc. (GMRE)

NYSE: GMRE · Real-Time Price · USD

6.67

-0.08 (-1.19%)

At close: Aug 15, 2025, 3:46 PM

Global Medical REIT Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	141.71M	137.96M	138.41M	136.39M	137.7M	139.8M	140.97M	144.34M	144.26M	141.62M	137.27M	131.27M	125.83M	120.35M	115.8M	110.39M	105.47M	99.31M
Cost of Revenue	29.8M	29.45M	29.25M	28.15M	27.94M	27.93M	28.08M	29.13M	28.58M	27.35M	25.19M	22.58M	19.87M	17.17M	15.49M	13.57M	13.22M	12.25M
Gross Profit	95.97M	108.48M	109.16M	108.24M	109.76M	111.87M	112.88M	115.21M	115.68M	114.27M	112.08M	108.7M	105.96M	103.18M	100.32M	96.81M	92.25M	87.06M
Operating Income	33.13M	33.09M	32.68M	34.64M	25.92M	27.39M	28.23M	29.89M	40.24M	39.61M	38.74M	38.78M	38.65M	38.66M	37.96M	35.64M	20.78M	17.73M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	10.65M	8.12M	6.69M	4.3M	5.75M	21.88M	21.73M	23.03M	28.23M	17.88M	20M	23.64M	18.98M	19.3M	18.34M	15.45M	499K	-1.99M
Net Income	10.29M	7.94M	6.63M	4.42M	5.77M	20.73M	20.61M	13.78M	17.24M	6.21M	8.19M	19.67M	16.75M	18.53M	17.62M	14.88M	924K	-1.43M
Selling & General & Admin	21.73M	20.3M	21.12M	17.64M	17.62M	17.5M	16.85M	16.68M	16.28M	16.15M	16.55M	16.43M	16.32M	16.27M	16.45M	16.95M	29.7M	30M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	41.11M	55.1M	55.36M	55.96M	66.21M	52.25M	53.06M	53.91M	44.43M	44.41M	42.7M	27.64M	13.24M	13.29M	133K	136K	162K	120K
Operating Expenses	62.84M	75.4M	76.48M	59.35M	59.89M	60.58M	60.74M	75.67M	75.48M	74.58M	73.27M	70.71M	68.13M	65.47M	63.33M	61.31M	71.64M	69.45M
Interest Expense	29.98M	28.96M	28.69M	28.1M	28.04M	29.51M	30.89M	31.97M	31.77M	28.7M	25.23M	21.97M	19.84M	19.46M	19.7M	19.95M	19.98M	19.34M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	92.64M	104.85M	105.73M	101.75M	111.78M	112.45M	112.76M	114.49M	104.06M	101.94M	98.46M	93.29M	88M	82.64M	78.82M	74.88M	84.86M	81.7M
Income Tax Expense	-178K	n/a	n/a	n/a	n/a	n/a	n/a	8.06M	8.06M	15.08M	15.08M	7.25M	7.25M	384K	496K	341K	341K	198K
Shares Outstanding (Basic)	66.88M	66.87M	66.84M	65.74M	65.59M	65.57M	65.56M	65.56M	65.54M	65.53M	65.52M	65.52M	65.51M	65.3M	64.33M	64.2M	61.19M	52.67M
Shares Outstanding (Diluted)	66.88M	66.87M	66.84M	65.74M	65.59M	65.57M	65.56M	65.56M	65.54M	65.53M	65.52M	65.52M	65.51M	65.3M	64.33M	64.2M	61.19M	52.67M
EPS (Basic)	0.07	0.05	0.06	0.05	0.09	0.29	0.29	0.19	0.24	0.09	0.12	0.29	0.25	0.29	0.29	0.26	-0.01	-0.04
EPS (Diluted)	0.07	0.05	0.06	0.05	0.09	0.29	0.29	0.19	0.24	0.09	0.12	0.29	0.25	0.29	0.29	0.26	-0.01	-0.04
EBITDA	97.53M	92.98M	91.46M	89.01M	90.94M	96.42M	98.15M	43.81M	42.2M	39.88M	36.05M	44.26M	40.78M	38.17M	36.17M	77.35M	60.91M	53.92M
EBIT	40.48M	37.08M	35.38M	32.41M	33.78M	42.33M	46.19M	50.6M	49.09M	44.74M	39.24M	34.92M	34.62M	34.59M	35.52M	35.56M	20.64M	17.49M
Depreciation & Amortization	57.05M	55.9M	56.08M	56.61M	57.16M	57.82M	58.48M	59.16M	59.2M	58.43M	56.72M	54.28M	51.81M	49.18M	46.84M	44.33M	41.96M	39.65M